{"id":847678,"date":"2025-05-06T16:41:10","date_gmt":"2025-05-06T20:41:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/"},"modified":"2025-05-06T16:41:10","modified_gmt":"2025-05-06T20:41:10","slug":"glenview-capital-issues-statement-on-cvs-health","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/","title":{"rendered":"Glenview Capital Issues Statement on CVS Health"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, May 6, 2025<\/span><\/span> \/PRNewswire\/ — One year ago, we established a concentrated position in shares of\u00a0CVS Health (NYSE: CVS). Since our purchases in May 2024,\u00a0CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company. \u00a0Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan:<\/p>\n

    \n
  1. \n Board Refreshment<\/b>\u00a0\u2013 The Board welcomed four new Directors including Larry Robbins<\/span>, Glenview’s CEO, and recently appointed a strong Lead Independent Director.\u00a0 The entire Board is operating cooperatively and cohesively;<\/p>\n<\/li>\n
  2. \n Strengthening Culture and Leadership<\/b>\u00a0\u2013 CVS’s leadership has undergone significant transformation under new CEO David Joyner’s<\/span> leadership, combining internal promotion with external recruitment while strengthening a customer-centric, accountable culture;<\/p>\n<\/li>\n
  3. \n Operational Intensity<\/b>\u00a0\u2013 CVS exceeded consensus earnings expectations over the past two quarters and has seen operating strength and early signs of recovery across its businesses;<\/p>\n<\/li>\n
  4. \n Risk Management<\/b>\u00a0\u2013 The Company has suspended material acquisitions, committed to deleveraging, strengthened its insurance reserve levels and established a clear path to sustainable returns on capital that will fuel future customer service and benefit stability;<\/p>\n<\/li>\n
  5. \n Portfolio Enhancement and Innovation<\/b>\u00a0\u2013 CVS has exited or transitioned certain lines of business where economics prevent a sustainable commitment to customers while leading the industry with transparent and value-added solutions to reduce cost and complexity; and<\/p>\n<\/li>\n
  6. \n Opportunistic Capital Deployment<\/b>\u00a0\u2013 In combination, CVS has marched closer to the time in which share repurchase can be both a responsible consideration and a creator of long-term shareholder value.\u00a0<\/li>\n<\/ol>\n

    Following healthy Q1 results and increased annual guidance, Glenview reduced its overall holdings by 3.75 million shares consistent with our fund’s diversification parameters and to create buying power for further unique opportunities in this volatile macro environment.\u00a0With this rebalancing, CVS Health remains our largest position, and we have no plans for additional adjustments to our CVS holdings.\u00a0 Our confidence in the near, medium, and long-term outlook for CVS remains strong.\u00a0<\/p>\n

    We are grateful for the engagement and enthusiasm of the entire CVS Health team in the revitalization efforts well underway and are fully committed to making continued contributions to the vitality and long-term success of this iconic institution that strengthens the health of 185 million people.<\/p>\n

    Together we grow.<\/p>\n

    \n About\u00a0Glenview Capital
    <\/b>In its 25th\u00a0year of operations, Glenview Capital is a long-term investment partnership focused on fundamental investing.<\/p>\n

    \n Contact:
    <\/b>
    \n Keegan Bales<\/span>
    \n
    \n kbales@hstrategies.com<\/a>\n <\/p>\n

    \n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/glenview-capital-issues-statement-on-cvs-health-302447757.html<\/a><\/p>\n

    SOURCE Glenview Capital<\/p>\n<\/p><\/div>\n

    \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

    PR Newswire NEW YORK , May 6, 2025 \/PRNewswire\/ — One year ago, we established a concentrated position in shares of\u00a0CVS Health (NYSE: CVS). Since our purchases in May 2024,\u00a0CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company. \u00a0Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan: Board Refreshment\u00a0\u2013 The Board welcomed four new Directors including Larry Robbins, Glenview’s CEO, and recently appointed a strong Lead Independent Director.\u00a0 The entire Board is operating cooperatively and cohesively; Strengthening Culture and Leadership\u00a0\u2013 CVS’s leadership has undergone significant transformation under new … <\/p>\n

    Continue reading “Glenview Capital Issues Statement on CVS Health”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-847678","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGlenview Capital Issues Statement on CVS Health - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glenview Capital Issues Statement on CVS Health - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , May 6, 2025 \/PRNewswire\/ — One year ago, we established a concentrated position in shares of\u00a0CVS Health (NYSE: CVS). Since our purchases in May 2024,\u00a0CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company. \u00a0Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan: Board Refreshment\u00a0\u2013 The Board welcomed four new Directors including Larry Robbins, Glenview’s CEO, and recently appointed a strong Lead Independent Director.\u00a0 The entire Board is operating cooperatively and cohesively; Strengthening Culture and Leadership\u00a0\u2013 CVS’s leadership has undergone significant transformation under new … Continue reading "Glenview Capital Issues Statement on CVS Health"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-06T20:41:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Glenview Capital Issues Statement on CVS Health\",\"datePublished\":\"2025-05-06T20:41:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/\"},\"wordCount\":421,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY81474&sd=2025-05-06\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/\",\"name\":\"Glenview Capital Issues Statement on CVS Health - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY81474&sd=2025-05-06\",\"datePublished\":\"2025-05-06T20:41:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY81474&sd=2025-05-06\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY81474&sd=2025-05-06\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glenview-capital-issues-statement-on-cvs-health\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glenview Capital Issues Statement on CVS Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glenview Capital Issues Statement on CVS Health - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/","og_locale":"en_US","og_type":"article","og_title":"Glenview Capital Issues Statement on CVS Health - Market Newsdesk","og_description":"PR Newswire NEW YORK , May 6, 2025 \/PRNewswire\/ — One year ago, we established a concentrated position in shares of\u00a0CVS Health (NYSE: CVS). Since our purchases in May 2024,\u00a0CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company. \u00a0Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan: Board Refreshment\u00a0\u2013 The Board welcomed four new Directors including Larry Robbins, Glenview’s CEO, and recently appointed a strong Lead Independent Director.\u00a0 The entire Board is operating cooperatively and cohesively; Strengthening Culture and Leadership\u00a0\u2013 CVS’s leadership has undergone significant transformation under new … Continue reading \"Glenview Capital Issues Statement on CVS Health\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-06T20:41:10+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Glenview Capital Issues Statement on CVS Health","datePublished":"2025-05-06T20:41:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/"},"wordCount":421,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/","name":"Glenview Capital Issues Statement on CVS Health - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06","datePublished":"2025-05-06T20:41:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY81474&sd=2025-05-06"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glenview-capital-issues-statement-on-cvs-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Glenview Capital Issues Statement on CVS Health"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=847678"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847678\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=847678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=847678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=847678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}